文献速递神经MR

卒中患者超敏急性再灌注标志物与眼部结构钆渗漏的系统综述

Hyperintense acute reperfusion marker and gadolinium leakage in ocular structures in stroke: a systematic review.
PubMed 文献 · Neuroradiology · 2025-05-13

该系统综述检索Embase、Scopus和PubMed至2022年7月,纳入38项卒中研究(仅6项评估眼部结构钆渗漏),分析超敏急性再灌注标志物与眼部结构钆渗漏在增强液体衰减反转恢复成像上的方法学挑战与混杂因素,发现两者患病率变异大(分别为5.5–85%和30–76%),方法学问题包括缺乏时间特异性数据、遗漏脑脊液高信号鉴别、定义不精确及未校正评估时机、对比剂剂量或肾功能等变量。

要点

  • 超敏急性再灌注标志物和眼部结构钆渗漏在卒中后增强FLAIR上患病率变异大,分别为5.5–85%和30–76%。
  • 方法学问题包括缺乏时间特异性数据、遗漏脑脊液高信号鉴别、定义不精确及未校正评估时机、对比剂剂量或肾功能等变量。
  • 结果差异主要源于研究时间窗不足,作者建议进一步研究应按钆注射时机对患者分层。

核心结论

  • 应更详细地探究超敏急性再灌注标志物和眼部结构钆渗漏的时机与定位,而非仅关注其二元存在、范围或严重程度。

研究设计与样本

  • 系统综述,检索Embase、Scopus和PubMed至2022年7月,纳入38项卒中研究,其中仅6项评估眼部结构钆渗漏;采用改良纽卡斯尔-渥太华量表进行偏倚风险评估,效应估计综合考量队列规模、统计学显著性和偏倚风险。

关键影像表现/征象

  • 超敏急性再灌注标志物和眼部结构钆渗漏是增强液体衰减反转恢复成像上的关键影像学表现,证实钆渗漏进入脑脊液。
  • 超敏急性再灌注标志物患病率范围为5.5–85%,眼部结构钆渗漏为30–76%。

临床应用与阅片要点

  • 作者认为,准确评估这些标志物可能对推进卒中病理生理学理解和改善临床管理至关重要。
  • 方法学问题包括缺乏时间特异性数据、遗漏脑脊液高信号鉴别、定义不精确及未校正评估时机、对比剂剂量或肾功能等变量。
  • 作者建议进一步研究应按钆注射时机对患者分层。

局限性

  • 方法学问题包括缺乏时间特异性数据、遗漏脑脊液高信号鉴别、定义不精确及未校正评估时机、对比剂剂量或肾功能等变量。
  • 结果差异主要源于研究时间窗不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: The Hyperintense Acute Reperfusion Marker (HARM) and Gadolinium Leakage in Ocular Structures (GLOS) are pivotal radiological findings in post-contrast fluid-attenuated inversion recovery imaging (pcFLAIR), attesting to gadolinium leakage into the cerebrospinal fluid (CSF) in various neurological disorders. Often observed following acute strokes, HARM and GLOS, however, exhibit considerable variability in their prevalence ranging from 5.5 to 85% and 30-76%, respectively. Given their similarity and association of HARM with poor outcomes in stroke, accurately evaluating these markers may be crucial for advancing our understanding of stroke pathophysiology and improving clinical management. Our work aims to identify the major methodological challenges and confounding factors limiting the understanding of HARM and GLOS in stroke.

METHODS: To address these issues, we thoroughly conducted a literature search in Embase, Scopus, and PubMed until July 2022. Our search yielded 38 stroke studies, with only 6 evaluating GLOS. Guided by major findings, we adapted the Newcastle-Ottawa scale for bias risk assessment. Effect estimates were synthetized considering cohort size, statistical significance, and bias risk.

RESULTS: Methodological issues emerged from the lack of time-specific data, omission of differential CSF hyperintensities, imprecise definitions, and overlooking of adjusting variables like assessment timing, contrast dosages or renal function. Discrepancy results mainly arise from an inadequate time window of investigation, and further research should stratify patients based on the timing of gadolinium injection.

CONCLUSION: Our findings emphasize the importance of a more detailed exploration of their timing and localization, rather than simply their binary presence, extent, or severity.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Bousfiha C, Saccaro LF, Consoli A, et al. Hyperintense acute reperfusion marker and gadolinium leakage in ocular structures in stroke: a systematic review. Neuroradiology. 2025. PMID: 40358714. doi:10.1007/s00234-025-03646-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。